<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The incidence of <z:hpo ids='HP_0012115'>hepatitis</z:hpo> B and C virus and <z:e sem="disease" ids="C0010823" disease_type="Disease or Syndrome" abbrv="">cytomegalovirus infection</z:e> is high in patients with the <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS) </plain></SENT>
<SENT sid="1" pm="."><plain>The specific features of <z:e sem="disease" ids="C0042769" disease_type="Disease or Syndrome" abbrv="">virus infection</z:e> in APS patients are determined by the activity of APS </plain></SENT>
<SENT sid="2" pm="."><plain>During clinically manifest stage, the activities of aminotransferases, <z:chebi fb="4" ids="24996">lactate</z:chebi> dehydrogenase (LDH), and alkaline phosphatase increase, while during remission only <z:chebi fb="0" ids="29995">aspartate</z:chebi> aminotransferase and LDH levels remain high, for this latter enzyme high activities of isoenzymes LDH5 and LDH4 being recorded </plain></SENT>
<SENT sid="3" pm="."><plain>These data indicate that the <z:mpath ids='MPATH_596'>pathological process</z:mpath> in APS involves not only the liver, but the sinusoidal endothelium as well </plain></SENT>
<SENT sid="4" pm="."><plain>This seems to account for some other clinical and laboratory manifestations of APS, such as increased level of circulating immune complexes, dysfunction of physiological <z:chebi fb="2" ids="50249">anticoagulants</z:chebi>, etc </plain></SENT>
</text></document>